| |
|
|
|
GenMark Diagnostics Inc.  
|
|
6.11 -0.24 (-0.04%) |
08-23 16:00 |
|
Open: |
6.33 |
Pre close: |
6.35 |
Target:
|
7.45 
|
|
High: |
6.335 |
Low: |
6.08 |
Resistance:
|
6.38
6.89
|
|
Volume: |
348,421 |
Market Cap: |
351M |
Support:
|
5.56
4.63
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.30
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
6.38 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
6.78 |
Stochastic Oscillator |
%K(14,3):
|
51.63 |
|
MA(250): |
6.45 |
%D(3): |
56.22 |
|
Average Volume(K) |
3-Month: |
34609
|
52-Week |
High:
|
8.81 |
|
10-Days: |
25059 |
Low: |
3.58 |
|
RSI |
RSI(14):
|
41.69 |
Change(%): |
-19.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.850 |
Return on Equity (ttm) |
-148.8 |
Shares Out. (M) |
55.96 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-29.7 |
Shares Float (M) |
45.42 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.19 |
% Held by Insiders |
6.60 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
23.0 |
% Held by Institutions |
95.90 |
|
Forward EPS |
-0.630 |
Gross Profit (p.s.) |
0.348 |
Shares Short (K) |
2020 |
|
Book Value (p.s.) |
0.260 |
EBITDA (p.s.) |
-0.658 |
P/E |
-7.19 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
23.50 |
|
Profit Margin |
-63.86 |
Operating Cash Flow
(M) |
-31.69 |
P/S |
257079408.00 |
|
Operating Margin |
-58.60 |
Levered Free Cash Flow
(M) |
-14.11 |
P/CF |
-10.79 |
|
|
|
|
|
|
